Hjem › Hode- og halskreft › Missouri › St. Louis
Kliniske studier for Hode- og halskreft i St. Louis, MO
15 studier for Hode- og halskreft søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RekruttererFase 2/3
- Site #0114, St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- Washington University, School of Medicine, St Louis
Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
Rekrutterer
- Washington University School of Medicine, St Louis
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Washington University, St Louis
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
Rekrutterer
- Washington University in St. Louis, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RekruttererObservasjonsstudie
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
RekruttererFase 1
- Washington University School of Medicine, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Washington University, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekruttererFase 1/2
- Saint Louis University, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
RekruttererObservasjonsstudie
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- Washington University Infusion Center Pharmacy, St Louis
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
RekruttererFase 3
- GSK Investigational Site, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Washington University School of Medicine, St Louis
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Rekrutterer
- Washington University in St. Louis, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, St Louis
Hode- og halskreft-studier i andre byer
- Houston, TX30 studier
- Boston, MA22 studier
- New York City, NY21 studier
- Nashville, TN21 studier
- Dallas, TX12 studier
- Pittsburgh, PA11 studier
- Los Angeles, CA10 studier
- San Antonio, TX10 studier
- Baltimore, MD10 studier
- Washington, DC10 studier
- Durham, NC10 studier
- Chicago, IL10 studier
Andre studier i St. Louis
- Ikke-småcellet lungekreft73 studier
- Brystkreft64 studier
- Metastatisk kreft54 studier
- Kolorektal kreft50 studier
- Kreft (alle typer)46 studier
- Prostatakreft46 studier
- Lungekreft39 studier
- Eggstokkreft38 studier
- Pankreaskreft33 studier
- Endometriekreft29 studier
- Plateepitelcancer i hode og hals28 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.